FDA's Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI's Multikine® to Address Major Treatment Gap for PD-L1 Negative Cancer Patients
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
HailTheApocalypse
Jaguar8
OP
:
oh ok. hope things are well . I mean, I know things could be better but just wanted to stop by and see how you were doing.
HailTheApocalypse : hey Jag, (if you don't mind me calling you that) how ya been?
Jaguar8 OP HailTheApocalypse : Still out. Just on my 40 mins break from my long evaluation
StockRoller Jaguar8 OP : Enjoy the break while you can
HailTheApocalypse Jaguar8 OP : oh ok. hope things are well . I mean, I know things could be better but just wanted to stop by and see how you were doing.